Evidence map›Paper›PMID 39734303›Full record

ArticleAnnals of hepato-biliary-pancreatic surgery2025

Propensity score analysis of adjuvant therapy in radically resected gallbladder cancers: A real world experience from a regional cancer center.

Sushma Agrawal, Rahul, Mohammed Naved Alam, Neeraj Rastogi, Ashish Singh, Rajneesh Kumar Singh, Anu Behari, Prabhakar Mishra

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hepato-biliary-pancreatic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sushma AgrawalDepartment of Radiotherapy, Sanjay Gandhi Post-graduate Institute of Medical Sciences, Lucknow, India.ORCID https://orcid.org/0000-0002-7260-6509
RahulDepartment of Surgical Gastroenterology, Sanjay Gandhi Post-graduate Institute of Medical Sciences, Lucknow, India.ORCID https://orcid.org/0000-0001-7690-6704
Mohammed Naved AlamDepartment of Radiotherapy, Sanjay Gandhi Post-graduate Institute of Medical Sciences, Lucknow, India.ORCID https://orcid.org/0000-0002-3766-0534
Neeraj RastogiDepartment of Radiotherapy, Sanjay Gandhi Post-graduate Institute of Medical Sciences, Lucknow, India.ORCID https://orcid.org/0009-0001-2168-7134
Ashish SinghDepartment of Surgical Gastroenterology, Sanjay Gandhi Post-graduate Institute of Medical Sciences, Lucknow, India.ORCID https://orcid.org/0000-0003-1954-772X
Rajneesh Kumar SinghDepartment of Surgical Gastroenterology, Sanjay Gandhi Post-graduate Institute of Medical Sciences, Lucknow, India.ORCID https://orcid.org/0000-0002-6977-9214
Anu BehariDepartment of Surgical Gastroenterology, Sanjay Gandhi Post-graduate Institute of Medical Sciences, Lucknow, India.ORCID https://orcid.org/0000-0003-1522-0869
Prabhakar MishraDepartment of Biostatistics and Health Informatics, Sanjay Gandhi Post-graduate Institute of Medical Sciences, Lucknow, India.ORCID https://orcid.org/0000-0003-4769-9106

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Backgrounds/Aims: Given the high mortality associated with gallbladder cancer (GBC), the efficacy of adjuvant therapy (AT) remains controversial. We audited our data over an 11-year period to assess the impact of AT. Methods: This study included all patients who underwent curative resection for GBC from 2007 to 2017. Analyses were conducted of clinicopathological characteristics, surgical details, and postoperative therapeutic records. The benefits of adjuvant chemotherapy (CT) or chemoradiotherapy (CTRT) were evaluated against surgery alone using SPSS version 20 for statistical analysis. Results: The median age of patients (n = 142) was 50 years. The median overall survival (OS) was 93, 34, and 30 months with CT, CTRT, and surgery alone respectively ( Conclusions: Radically resected GBC patients appear to benefit more from adjuvant CT, while CTRT should be reserved for cases with high-risk features.

Indexed as

Chemotherapy adjuvantGallbladder neoplasmPropensity scoreRadiotherapy

Identifiers

PMID39734303
PMCPMC11830902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.